Skip to content
Back to DRTS

Alpha Tau Medical Ltd.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
12
Purchases
0
Sales
12
Purchase value
$0.00
Sale value
$1.01M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

3 rows are listed but not counted: their filed prices fail a plausibility check, or they are not common stock.

Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 25, 2026Period of report Aug 21, 20260001213900-26-093335
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 21, 2026
Ordinary Shares2,871$15.0028$43.07K90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 11, 20260001213900-26-088176
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 11, 2026
Ordinary Shares17,730$14.0032$248.28K90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 6, 20260001213900-26-075747
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Ordinary Shares2,270$14.0011$31.78K90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 2, 20260001213900-26-075309
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 2, 2026
Ordinary Shares17,873$13.0027$232.40K90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001213900-26-074749
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Ordinary Shares2,127$13.0189$27.69K90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 1, 2026Period of report Jun 30, 20260001213900-26-074011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 30, 2026
Ordinary Shares20,000$12.0022Not counted90,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 26, 2026Period of report Jun 25, 20260001213900-26-072349
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 25, 2026
Ordinary Shares4,222$11.0002$46.44K125,958Direct
SaleJun 25, 2026
Ordinary Shares15,778$11.0002Not counted110,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 25, 2026Period of report Jun 23, 20260001213900-26-071830
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 23, 2026
Ordinary Shares15,000$9.47Not counted132,680Direct
SaleJun 23, 2026
Ordinary Shares2,500$10.0004$25.00K130,180Direct
Open on SEC EDGAR
Raphi LevyChief Financial Officer
4
Filed Jun 4, 2026Period of report Jun 3, 20260001213900-26-065201
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Ordinary Shares17,500$10.9005$190.76K162,680Direct
SaleJun 3, 2026
Ordinary Shares15,000$10.7571$161.36K147,680Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.